Suche
Ihre Suche nach "%2A" ergab 95 Treffer
×
Johannes Gutenberg-Universität Mainz
- Moog, Gero; Mauss, Stefan; Hueppe, Dietrich et al.
- Efficacy of Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1: The PAN Study
- GASTROENTEROLOGY. Bd. 144. H. 5. 2013 S. S982-S982
- Moog, Gero; Mauss, Stefan; Hueppe, Dietrich et al.
- Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study
- GASTROENTEROLOGY. Bd. 144. H. 5. 2013 S. S980-S980
- Jensen, Donald M.; Asselah, Tarik; Dieterich, Douglas T. et al.
- A pooled analysis of two randomized, double-blind placebo-controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C genotype-1 infection
- HEPATOLOGY. Bd. 58. 2013 S. 734A-735A
- Mauss, S; Boeker, K; Zehnter, E et al.
- POTENTIAL RELEVANCE OF VIRAL RESPONSE AT WEEK 8 AS A PREDICITIVE FACTOR FOR SVR IN GENOTYPE 1 INFECTED CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN REAL LIFE SETTING
- HEPATOLOGY. Bd. 52. H. 4. 2010 S. 777A-777A
- Berg, T; Dieterich, DT; Lalezari, JP et al.
- VIROLOGICAL RESPONSE AND SAFETY OF 4 WEEKS TREATMENT WITH THE PROTEASE INHIBITOR BI 201335 COMBINED WITH 48 WEEKS OF PEGINTERFERON ALFA 2A AND RIBAVIRIN FOR TREATMENT OF HCV GT-1 PATIENTS WHO FAILED PEGINTERFERON/RIBAVIRIN
- HEPATOLOGY. Bd. 52. H. 4. 2010 S. 704A-705A
- Pleimes, Dirk; Moebus, Volker; Mayer, Frank et al.
- Induced Myerosuppression and Recommendation for Monitoring of Absolute Neutrophil Counts in Patients Treated with Epirubicin and Cyclophosphamide in Early Breast Cancer: Results from a Phase 2a Collaborative Trial of the AGO-B and CESAR Study Groups
- BLOOD. Bd. 132. 2018
- Moog, Gero; Mauss, Stefan; Hueppe, Dietrich et al.
- Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaiVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment
- GASTROENTEROLOGY. Bd. 144. H. 5. 2013 S. S982-S983
- Chakrabarti, Anjan K.; Feeney, Kristin; Abueg, Cassandra et al.
- Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction
- AMERICAN HEART JOURNAL. Bd. 165. H. 4. 2013 S. 509-+
- Einfluss von All-trans-Retinsäure auf die Viruskinetik bei Non-Respondern mit chronischer HCV-Typ1-Infektion. Atraction
- Schuchmann, Marcus; (2007 - 2010)
- Hemmung kationischer Aminosäuretransporter durch Lanthanide
- Nawrath, Hermann; (2005 - 2007)